Genetic and Immunological Characterization of Brain Metastases from Solid Cancers.
Deguchi S, Akiyama Y, Mitsuya K, Ikeya T, Hozumi C, Iizuka A, Miyata H, Maeda C, Ashizawa T, Nagashima T, Urakami K, Ohshima K, Muramatsu K, Sugino T, Ohde Y, Tsubosa Y, Nishimura S, Yamaguchi K.
Deguchi S, et al.
Anticancer Res. 2024 May;44(5):1983-1994. doi: 10.21873/anticanres.17001.
Anticancer Res. 2024.
PMID: 38677762
BACKGROUND/AIM: Brain metastasis, a leading cause of cancer death, is a clinical challenge. ...CONCLUSION: High TMB in metastatic lesions indicates potential benefit from immune checkpoint inhibitor usage for brain metastasis and TREML2 and BTLA are factors a …
BACKGROUND/AIM: Brain metastasis, a leading cause of cancer death, is a clinical challenge. ...CONCLUSION: High TMB in metastatic les …